Jinyu Bio-technology Co., Ltd. (SHA:600201)

Jinyu Bio-technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,010	1,140	1,712	1,405	1,334	1,516
Trading Asset Securities	36.74	36.83	37.27	46.94	183.85	639.48
Cash & Short-Term Investments	1,046	1,176	1,749	1,452	1,518	2,156
Cash Growth	-39.16%	-32.76%	20.46%	-4.32%	-29.58%	21.03%
Accounts Receivable	697.28	648.83	869.84	816.65	742.88	627.65
Other Receivables	36.71	45.14	44.37	57.29	41.49	36.04
Receivables	734	693.97	914.21	873.94	904.5	663.69
Inventory	285.44	294.64	322.25	333.46	317.65	350.66
Prepaid Expenses	-	3.49	3.45	-	1.07	1.07
Other Current Assets	32.6	22.93	26.51	20.91	19.4	16.08
Total Current Assets	2,099	2,191	3,016	2,681	2,761	3,187
Property, Plant & Equipment	1,796	1,830	1,892	1,799	1,819	1,720
Long-Term Investments	482.2	1,829	1,025	1,019	1,058	445.75
Goodwill	8.2	8.2	11.41	29.49	94.5	134.26
Other Intangible Assets	584.9	586.76	352.12	347.32	388.45	343.48
Long-Term Deferred Tax Assets	106.01	107.36	96.99	83.43	86.15	81.75
Long-Term Deferred Charges	56.78	69.84	378.12	322.53	260.16	238.7
Other Long-Term Assets	1,566	142.28	100.48	107.87	136.86	127.5
Total Assets	6,699	6,765	6,873	6,389	6,604	6,278
Accounts Payable	289.11	295.84	324.41	354.41	347.05	330.32
Accrued Expenses	27.19	58.85	76.96	101.36	102.82	79.99
Short-Term Debt	15.01	15.01	-	10.01	-	-
Current Portion of Leases	1.39	1.48	1.53	0.53	0.62	-
Current Income Taxes Payable	18.88	4.07	6.92	13.39	7.82	12.96
Current Unearned Revenue	84.35	105.14	98.38	84.65	82.55	80.36
Other Current Liabilities	238.44	244.67	332.25	94.39	148.29	175.9
Total Current Liabilities	674.37	725.06	840.45	658.75	689.15	679.53
Long-Term Leases	0.77	1.25	2.73	0.31	0.16	-
Long-Term Unearned Revenue	339.32	345.32	364.84	370.49	343.9	325.42
Long-Term Deferred Tax Liabilities	8.95	9.36	9.63	10.15	10.48	10.38
Other Long-Term Liabilities	268.29	268.29	-	-	-	-
Total Liabilities	1,292	1,349	1,218	1,040	1,044	1,015
Common Stock	1,120	1,120	1,120	1,120	1,126	1,126
Additional Paid-In Capital	764.33	764.9	891.52	834.3	893.34	886.67
Retained Earnings	3,741	3,693	3,673	3,456	3,366	3,119
Treasury Stock	-309.55	-209.67	-338.48	-338.48	-113.34	-150.02
Comprehensive Income & Other	-12.22	-53.9	20.46	-0.41	-0.23	-0.2
Total Common Equity	5,303	5,314	5,367	5,072	5,272	4,982
Minority Interest	103.76	101.04	288.06	277.45	287.98	281.28
Shareholders' Equity	5,407	5,415	5,655	5,350	5,560	5,263
Total Liabilities & Equity	6,699	6,765	6,873	6,389	6,604	6,278
Total Debt	17.17	17.74	4.27	10.85	0.78	-
Net Cash (Debt)	1,029	1,159	1,745	1,442	1,517	2,156
Net Cash Growth	-40.00%	-33.61%	21.07%	-4.99%	-29.61%	23.82%
Net Cash Per Share	0.94	1.06	1.60	1.30	1.35	1.91
Filing Date Shares Outstanding	1,093	1,117	1,117	1,087	1,103	1,119
Total Common Shares Outstanding	1,093	1,117	1,117	1,087	1,103	1,119
Working Capital	1,424	1,466	2,175	2,022	2,071	2,507
Book Value Per Share	4.85	4.76	4.80	4.66	4.78	4.45
Tangible Book Value	4,710	4,719	5,003	4,695	4,789	4,504
Tangible Book Value Per Share	4.31	4.22	4.48	4.32	4.34	4.03
Buildings	-	1,274	1,153	1,152	1,128	1,040
Machinery	-	1,451	1,354	50.02	1,272	1,244
Construction In Progress	-	201.48	359.22	151.72	128.74	20.93

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.